©The Author(s) 2025.
World J Gastrointest Oncol. Sep 15, 2025; 17(9): 106868
Published online Sep 15, 2025. doi: 10.4251/wjgo.v17.i9.106868
Published online Sep 15, 2025. doi: 10.4251/wjgo.v17.i9.106868
Table 2 Hazard ratios for overall survival and disease-free survival in hypercoagulation
| Outcome | HR | P value |
| OS | 4.436 | 0.023 |
| DFS | 2.551 | 0.039 |
- Citation: Christodoulidis G, Bartzi D, Tsagkidou K, Koumarelas KE, Zacharoulis D. Status quo of hypercoagulation as a prognostic indicator following neoadjuvant immunochemotherapy in locally advanced gastric cancer. World J Gastrointest Oncol 2025; 17(9): 106868
- URL: https://www.wjgnet.com/1948-5204/full/v17/i9/106868.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i9.106868